questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Composés benzhydryliques : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques : Questions médicales les plus fréquentes",
"headline": "Composés benzhydryliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés benzhydryliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diphénhydramine",
"alternateName": "Diphenhydramine",
"url": "https://questionsmedicales.fr/mesh/D004155",
"about": {
"@type": "MedicalCondition",
"name": "Diphénhydramine",
"code": {
"@type": "MedicalCode",
"code": "D004155",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"alternateName": "Methylenebis(chloroaniline)",
"url": "https://questionsmedicales.fr/mesh/D008753",
"about": {
"@type": "MedicalCondition",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"code": {
"@type": "MedicalCode",
"code": "D008753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modafinil",
"alternateName": "Modafinil",
"url": "https://questionsmedicales.fr/mesh/D000077408",
"about": {
"@type": "MedicalCondition",
"name": "Modafinil",
"code": {
"@type": "MedicalCode",
"code": "D000077408",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"url": "https://questionsmedicales.fr/mesh/D009966",
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"alternateName": "Benzhydryl Compounds",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Loyd V Allen",
"url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen",
"affiliation": {
"@type": "Organization",
"name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com."
}
},
{
"@type": "Person",
"name": "Jonas Bresien",
"url": "https://questionsmedicales.fr/author/Jonas%20Bresien",
"affiliation": {
"@type": "Organization",
"name": "Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de."
}
},
{
"@type": "Person",
"name": "Jose M Goicoechea",
"url": "https://questionsmedicales.fr/author/Jose%20M%20Goicoechea",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Alexander Hinz",
"url": "https://questionsmedicales.fr/author/Alexander%20Hinz",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moritz T Scharnhölz",
"url": "https://questionsmedicales.fr/author/Moritz%20T%20Scharnh%C3%B6lz",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of Extended and Combined Exposure of Bisphenol Compounds on Their Chromosome-Damaging Effect─Increased Potency and Shifted Mode of Action.",
"datePublished": "2022-12-26",
"url": "https://questionsmedicales.fr/article/36571243",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.est.2c06064"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of N-Aryl Para-Benzhydryl Substituent on the Thermal Stability of α-Diimine Nickel Catalyst.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37293788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/marc.202300221"
}
},
{
"@type": "ScholarlyArticle",
"name": "Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36559094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics14122600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Synthesis of Benzhydryl-Substituted Amines by Silanolate-Mediated Aldimine Arylation with Functionalized Aryl Nucleophiles Released from Diazene-Based Reagents.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36469587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.orglett.2c03798"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the budget impact of Empagliflozin in managing heart failure with reduced ejection fraction: Proposing strategic policies for Malaysian public healthcare.",
"datePublished": "2024-10-31",
"url": "https://questionsmedicales.fr/article/39480849",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0313131"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés benzhydryliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés benzhydryliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés benzhydryliques",
"description": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une surdose ?\nComment différencier les effets des composés benzhydryliques ?\nQuels signes cliniques sont associés à ces composés ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés benzhydryliques",
"description": "Quels sont les symptômes courants d'une exposition ?\nPeut-on avoir des réactions cutanées ?\nQuels effets neurologiques peuvent se manifester ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon la dose ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés benzhydryliques",
"description": "Comment prévenir l'exposition aux composés benzhydryliques ?\nY a-t-il des formations recommandées ?\nQuels sont les conseils de stockage sécuritaire ?\nComment sensibiliser le personnel aux risques ?\nQuelles sont les réglementations à suivre ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés benzhydryliques",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nComment gérer les symptômes neurologiques ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il envisager une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés benzhydryliques",
"description": "Quelles complications peuvent survenir après une exposition ?\nLes effets à long terme sont-ils possibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés benzhydryliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il le risque d'effets ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales affectent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001559?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests de laboratoire spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et urinaires peuvent détecter la présence de ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, somnolence et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment différencier les effets des composés benzhydryliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation clinique complète et l'historique des médicaments sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à ces composés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des anomalies neurologiques et des troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des maux de tête."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des réactions cutanées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et des démangeaisons peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets neurologiques peuvent se manifester ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la coordination et des convulsions peuvent se produire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés respiratoires et une respiration rapide peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux composés benzhydryliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection lors de la manipulation de ces substances."
}
},
{
"@type": "Question",
"name": "Y a-t-il des formations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la manipulation sécurisée des produits chimiques sont conseillées."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils de stockage sécuritaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Stocker dans des contenants étiquetés et dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des sessions d'information régulières sur les dangers des composés."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations à suivre ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les réglementations locales et nationales sur la manipulation des produits chimiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'administration de charbon actif et une surveillance médicale."
}
},
{
"@type": "Question",
"name": "Des antidotes spécifiques existent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les composés benzhydryliques."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les crises."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour aider à éliminer les toxines du corps."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et respiratoires peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les effets à long terme sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme sur la santé peuvent survenir après une exposition prolongée."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition et le cancer."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en respectant les mesures de sécurité et en évitant l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'effets ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition dans des environnements mal ventilés augmente le risque."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme et l'alcoolisme peuvent exacerber les effets des composés."
}
}
]
}
]
}
Bisphenol (BP) compounds are important environmental pollutants and endocrine disruptors. BPs are capable of inducing DNA/chromosome breaks (clastogenesis, involved in carcinogenesis), which requires ...
The thermal stability of α-diimine nickel catalysts has always been the focus of research. The introduction of large groups in the backbone or N-aryl ortho-position is a relatively mature solution. Ho...
Isoform-selective histone deacetylase (HDAC) inhibition is promoted as a rational strategy to develop safer anti-cancer drugs compared to non-selective HDAC inhibitors. Despite this presumed benefit, ...
A transition-metal-free protocol for the arylation of...
Sodium-glucose co-transporter-2 (SGLT2) inhibitors such as Empagliflozin, are increasingly recommended as part of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection frac...
Diabetes mellitus (DM) is associated with premature atherosclerotic disease, coronary artery disease (CAD) and chronic heart failure (HF), leading to increased morbidity and mortality. Sodium-Glucose ...
A prospective single-center study included patients with DM and stable CAD who were started on an SGLT2i (empagliflozin). Peripheral blood samples were collected at baseline, 1 month, and 3 months to ...
Eighteen patients were included in the study (median age 73, (IQR 69, 77) years, 67% male). After 1 month of treatment with empagliflozin, there was no significant change in cEPCs level or function. H...
Empagliflozin treatment in patients with DM and stable CAD increases cEPC levels and function, implying a cardioprotective mechanism. These findings highlight the potential of SGLT2i in treating cardi...
This study was aimed to evaluate whether the dose-response relationship of the sodium glucose co-transporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)-canagliflozin, dapa...
Diabetic osteoporosis (DOP) is a metabolic disease that occurs in patients with diabetes due to insufficient insulin secretion. This condition can lead to sensory neuropathy, nephropathy, retinopathy,...
This quasi-experimental study enrolled 100 patients with diabetic osteoporosis from February 2023 to February 2024. Participants were randomly assigned to an intervention group (n = 50) and a control ...
After six months of treatment, the intervention group exhibited significantly lower levels of FBG (P < 0.001), 2 h-PG (P = 0.001), and HbA1c (P < 0.001) than the control group. Additionally, bone mine...
Empagliflozin, when combined with symptomatic treatment, demonstrates a positive clinical effect in patients with diabetic osteoporosis. The treatment effectively improves blood glucose metabolism, bo...
The development of epoxy resins is mainly dependent on non-renewable petroleum resources, commonly diglycidyl ether bisphenol A (DGEBA)-type epoxy monomers. Most raw materials of these thermoset resin...
To evaluate the clinical and economic effectiveness of dapagliflozin in patients with chronic heart failure (CHF) with reduced left ventricular ejection fraction (HFrEF) in the Russian Federation in v...
A clinical and economic analysis of the use of the drug dapagliflozin in addition to standard therapy was carried out in comparison with standard therapy in various subgroups of standard therapy for H...
The present study demonstrates that the addition of dapagliflozin is beneficial in terms of clinical and cost-effectiveness, regardless of the initial regimen (angiotensin receptor-neprilysin inhibito...